Cargando…
Challenges for management of the COVID-19 epidemic in Iran
Autores principales: | Doosti-Irani, Amin, Mostafavi, Ehsan, Nazemipour, Maryam, Mansournia, Mohammad Ali, Haghdoost, Ali-Akbar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7525261/ https://www.ncbi.nlm.nih.gov/pubmed/33015615 http://dx.doi.org/10.1016/j.gloepi.2020.100035 |
Ejemplares similares
-
How Can the Epidemic Curve of COVID-19 in Iran Be Interpreted?
por: Doosti-Irani, Amin, et al.
Publicado: (2020) -
The Dynamic Effective Reproductive Number of COVID-19 during the Epidemic in Iran
por: Doosti-Irani, Amin, et al.
Publicado: (2022) -
Comparison of corticosteroids types, dexamethasone, and methylprednisolone in patients hospitalized with COVID-19: A systematic review and network meta-analysis
por: Morsali, Mina, et al.
Publicado: (2023) -
Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran
por: Nazemipour, Maryam, et al.
Publicado: (2021) -
Major infectious diseases affecting the Afghan immigrant population of Iran: a systematic review and meta-analysis
por: Pourhossein, Behzad, et al.
Publicado: (2015)